Earticle

현재 위치 Home

Review Article

Efficacy of AMXs, Natural Filaggrin and TNF-alpha Modulators containing V. amygdalina leaf Extracts, on Inflammatory Skin Diseases

첫 페이지 보기
  • 발행기관
    선문효정학술연구회 바로가기
  • 간행물
    The Journal of Sciences and Innovation for Sustainable Peace(구 The journal of Hyojeong Academia) 바로가기
  • 통권
    Vol. 3 No. 2 (2025.10)바로가기
  • 페이지
    pp.65-71
  • 저자
    Luzitu Severin Nangana, Nlandu Roger Ngatu, Marie Nsimba-Miezi, Christian Wansu-Mapong, Yukimi Nakamura, Jose Lami-Nzunzu
  • 언어
    영어(ENG)
  • URL
    https://www.earticle.net/Article/A481835

※ 기관로그인 시 무료 이용이 가능합니다.

4,000원

원문정보

초록

영어
Environmental inflammatory skin diseases, such as atopic dermatitis (AD) and contact dermatitis (CD) are common skin disorders in both industrialized and developing countries. They are characterized by a defect of the skin barrier and increased inflammatory response. Worldwide, the prevalence of environmental and occupational dermatitis has increased exponentially during the COVID-19 pandemic due to the elevated utilization of disinfectants and personal protective equipment (PPE). Steroids have long been used as the first-line treatment for dermatitis; but consid ering their side effects and contraindications, there is a need of effective treatments with better safety profile. This mini-review and case report highlights the skin health benefits of African plant V. amyg-dalina leaf extracts (AMXs). Our research team was the first to explore the beneficial health effects of AMXs in animal models of atopic (AD) and contact dermatitis (CD). It was observed that the water (AMX1) and ethanolic (AMX2) leaf extracts were as effective as topical steroid preparation in preventing and alleviating AD and CD, as well as in relieving itch, skin erosion and excoriation. Another study (immuno-fluorescence assay) showed that AMX and AMX-contained Vernodalin both have significantly increased the production of filaggrin (FLG) in mouse skin and reduced plasma TNF-alpha (vs. steroid). In our clinical investigation in patients with moderate to severe AD and CD, AMX1 and AMX2 were as effective as steroid preparation; but relatively more effective in relieving itch and healing wounded skin. Four clinical cases of African and Japanese CD patients successfully treated with AMX2 are also presented. Research findings and observations from recent CD cases suggest that AMXs are effective and could be used as therapeutic alternative to steroids, with a better safety profile, in the management of inflammatory skin diseases, particularly AD and CD.

목차

Abstract
1. Introduction
1.1. Atopic Dermatitis
1.2. Contact Dermatitis
1.3. Vernonia amygdalina: A African Plant with Numerous Health Benefits
2. Animal studies
2.1. Animal model of Allergic contact dermatitis (ACD)
2.2. Treatments and Approach used to assess the disease severity in animals
2.3. Main findings
3. Clinical investigation
3.1. Treatments
3.2. Assessment of the Severity of Skin Lesions in Patients
4. Case reports
4.1. Case 1: Allergic contact dermatitis in a female Japanese healthcare worker in Kagawa prefecture
4.2. Case 2: Rapidly evolving tumor-like dyschromic eczematous skin disorder in a male African doctor
4.3. Case 3: Pre-cancerous chronic and recalcitrant photodermatitis in a Congolese albino boy
5. Discussion and Conclusion
References

키워드

Atopic dermatitis Contact dermatitis Eczema area severity index (EASI) Vernonia amygdalina

저자

  • Luzitu Severin Nangana [ Congo-Japan Noncommunicable diseases (NCDs) Research Group/Service de Medicine Preventive, Centre de Sante de Reference Kimbanguiste de Makala, Kinshasa, D.R. Congo ]
  • Nlandu Roger Ngatu [ Congo-Japan Noncommunicable diseases (NCDs) Research Group/Kagawa University Faculty of Medicine, Kagawa, Japan ] Corresponding Author
  • Marie Nsimba-Miezi [ Congo-Japan Noncommunicable diseases (NCDs) Research Group/ Department of Biopharmaceuticals and Foof Science, Faculty of Pharmaceutical Sciences, Universiy of Kinshasa, Kinshasa, D.R. Congo ]
  • Christian Wansu-Mapong [ Congo-Japan Noncommunicable diseases (NCDs) Research Group/Faculty of Dental Medicine, University of Kinshasa ]
  • Yukimi Nakamura [ Congo-Japan Noncommunicable diseases (NCDs) Research Group ]
  • Jose Lami-Nzunzu [ Congo-Japan Noncommunicable diseases (NCDs) Research Group/Department of Medical Chemistry and Pharmacognosy, Faculty of Pharmaceutical Sciences, Universiy of Kinshasa ]

참고문헌

자료제공 : 네이버학술정보

간행물 정보

발행기관

  • 발행기관명
    선문효정학술연구회 [Sun Moon Hyojeong Academy Society]
  • 설립연도
    2023
  • 분야
    복합학>학제간연구
  • 소개
    Journal of Hyojeong Academia aims to serve as a global platform where researchers and scholars of various disciplines can contribute ideas for our sustainable global community of Co‐existence, Co‐prosperity, and Co‐righteousness. The journal is a multidisciplinary, open‐access, internationally peer‐reviewed academic journal, and it invites all areas of research conducted in the spirit of post materialism including studies centering on God, studies unifying religions and sciences, and studies on all aspects of Co‐existence, Co‐prosperity, and Co‐righteousness.

간행물

  • 간행물명
    The Journal of Sciences and Innovation for Sustainable Peace(구 The journal of Hyojeong Academia)
  • 간기
    반년간
  • pISSN
    2982-9305
  • 수록기간
    2023~2026
  • 십진분류
    KDC 238 DDC 289

이 권호 내 다른 논문 / The Journal of Sciences and Innovation for Sustainable Peace(구 The journal of Hyojeong Academia) Vol. 3 No. 2

    피인용수 : 0(자료제공 : 네이버학술정보)

    함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.

      페이지 저장